Search - tctmd.com

Displaying 121 - 140 of 220

Sort: Relevancy | Date

Presentation TCT 2019

Assessment of Volume Status (Cardiomems, Endotronix, Sensible)

Presenter: JoAnn Lindenfeld

September 28, 2019

Presentation TCT 2019

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Presenter: Peter Carson

September 28, 2019

Presentation TCT 2019

State of the Art: Device-Based Therapies for Heart Failure and Reduced EF

Presenter: Nir Uriel

September 28, 2019

Presentation TCT 2019

State of the Art: Current and Future of Medical Therapies for HF

Presenter: Clyde Yancy

September 28, 2019

News Industry News

preCARDIA Enrolls First Patient in Early Feasibility Study

August 15, 2019

News Industry News

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

July 15, 2019

News Conference News ESC Heart Failure 2019

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Shelley Wood

May 25, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Conference News SCAI 2019

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Yael L. Maxwell

May 22, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Todd Neale

November 10, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

Presentation TCT 2018

Ventricular Counterpulsation for Percutaneous Ventricular Support: PulseCath

Presenter: Nir Uriel, Hadley Wilson, Joost Daemen

September 22, 2018

Presentation TCT 2018

NuPulse: Implantable Counterpulsation for Advanced CHF

Presenter: Nir Uriel, Hadley Wilson, Valluvan Jeevanandam

September 22, 2018

Presentation TCT 2018

Percutaneous Ventricular and Pulmonary Support: TandemLife

Presenter: Nir Uriel, Hadley Wilson, Biswajit Kar

September 22, 2018

Advertisement

Assessment of Volume Status (Cardiomems, Endotronix, Sensible)

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

State of the Art: Device-Based Therapies for Heart Failure and Reduced EF

State of the Art: Current and Future of Medical Therapies for HF

preCARDIA Enrolls First Patient in Early Feasibility Study

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

TCTMD’s Top 10 Most Popular Stories for December 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Ventricular Counterpulsation for Percutaneous Ventricular Support: PulseCath

NuPulse: Implantable Counterpulsation for Advanced CHF

Percutaneous Ventricular and Pulmonary Support: TandemLife

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content